Cytosorbents Corporation Stock News

So far Sunday, April 26, NASDAQ is up 2.31% and the S&P is up 2.24%. Here are this morning’s most

So far Saturday, April 25, NASDAQ is up 2.31% and the S&P is up 2.24%. Here are this morning’s most

So far Friday, April 24, NASDAQ is down -0.25% and the S&P is down -0.51%. Let’s take a look at

Stocks Analysis by Harry Boxer covering: Apache Corporation, Mallinckrodt, Kirkland Lake Gold Ltd, Delek Logistics Partners LP. Read Harry Boxer's latest article on Investing.com

So far Tuesday, April 21, NASDAQ is down -6.89% and the S&P is down -2.44%. Let’s take a look at

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically

Cytosorbents CEO Dr. Phillip Chan told TheStreet his company's blood purification product for Covid-19 patients could be in hospitals and in use by next week.

DexCom (NASDAQ:DXCM) and Cytosorbents (NASDAQ:CTSO) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional o

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically

The following is a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) * Chembio Diagnostics Inc (NASDAQ: CEMI)

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) Chembio...